Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258141
Status:
UNKNOWN
Last Update Posted:
2005-11-24
First Post:
2005-11-23
Brief Title:
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
Sponsor:
J Uriach and Company
Organization:
J Uriach and Company
Study Overview
Official Title:
A Placebo-Controlled Double-Blind Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects
Status:
UNKNOWN
Status Verified Date:
2005-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites
Detailed Description:
Mosquito-bite symptoms include wheals and pruritic bite papules Oral antihistamines have shown to decrease whealing ang accompanying pruritus in placebo-controlled trials
Subjects will be treated for 4 days and exposed to experimental mosquito bite at day 3
Subjects will be treated for 4 days and exposed to experimental mosquito bite at day 3
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None